These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 36273222)
1. Evaluating the impact of price regulation (Drug Price Control Order 2013) on antibiotic sales in India: a quasi-experimental analysis, 2008-2018. Selvaraj S; Farooqui HH; Mehta A; Mathur MR J Pharm Policy Pract; 2022 Oct; 15(1):68. PubMed ID: 36273222 [TBL] [Abstract][Full Text] [Related]
2. Does price regulation affect atorvastatin sales in India? An impact assessment through interrupted time series analysis. Selvaraj S; Farooqui HH; Mehta A BMJ Open; 2019 Jan; 9(1):e024200. PubMed ID: 30679294 [TBL] [Abstract][Full Text] [Related]
3. The impact of stringent prescription-only antimicrobial sale regulation (Schedule H1) in India: an interrupted time series analysis, 2008-18. Farooqui HH; Selvaraj S; Mehta A; Mathur MR JAC Antimicrob Resist; 2020 Sep; 2(3):dlaa076. PubMed ID: 34223031 [TBL] [Abstract][Full Text] [Related]
4. Impact of the Drug Prices Control Order (2013) on the Utilization of Anticancer Medicines in India: An Interrupted Time-Series Analysis. Sharma B; Mehta A; Farooqui HH; Negandhi H; Selvaraj S Cureus; 2022 Jun; 14(6):e26367. PubMed ID: 35911346 [TBL] [Abstract][Full Text] [Related]
5. Injectable antibiotic use in India: public-private share in volume and cost. Fazaludeen Koya S; Ganesh S; Klemperer K; Yadav P; McDonnell A Wellcome Open Res; 2024; 9():70. PubMed ID: 39221437 [TBL] [Abstract][Full Text] [Related]
6. Influence of Government Price Regulation on the Price, Volume and Spending of Antibiotics in China: A Controlled Interrupted Time Series Study. Wushouer H; Luo Z; Guan X; Shi L Int J Health Policy Manag; 2022 Feb; 11(2):218-223. PubMed ID: 32702801 [TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies. Acosta A; Ciapponi A; Aaserud M; Vietto V; Austvoll-Dahlgren A; Kösters JP; Vacca C; Machado M; Diaz Ayala DH; Oxman AD Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005979. PubMed ID: 25318966 [TBL] [Abstract][Full Text] [Related]
8. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020. Yıldız M; Osman E Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516 [TBL] [Abstract][Full Text] [Related]
9. Research Letter: Antihypertensive Drugs Market in India: An Insight on Size, Trends, and Prescribing Preferences in the Private Health Sector, 2016-2018. Sahoo SK; Pathni AK; Krishna A; Moran AE; Cohn J; Bhatia S; Maheshwari N; Sharma B Glob Heart; 2021; 16(1):51. PubMed ID: 34381673 [TBL] [Abstract][Full Text] [Related]
10. Association Between the Percentage of US Drug Sales Subject to Inflation Penalties and the Extent of Drug Price Increases. Dickson S JAMA Netw Open; 2020 Sep; 3(9):e2016388. PubMed ID: 32915237 [TBL] [Abstract][Full Text] [Related]
11. Consumption of systemic antibiotics in India in 2019. Koya SF; Ganesh S; Selvaraj S; Wirtz VJ; Galea S; Rockers PC Lancet Reg Health Southeast Asia; 2022 Sep; 4():100025. PubMed ID: 37383993 [TBL] [Abstract][Full Text] [Related]
12. Systemic antibiotic sales and WHO recommendations, India. Mehta A; Brhlikova P; McGettigan P; Pollock AM; Roderick P; Farooqui HH Bull World Health Organ; 2022 Oct; 100(10):610-619. PubMed ID: 36188020 [TBL] [Abstract][Full Text] [Related]
13. Evaluating the impact of the single exit price policy on a basket of originator medicines in South Africa from 1999 to 2014 using a time series analysis. Moodley R; Suleman F BMC Health Serv Res; 2019 Aug; 19(1):576. PubMed ID: 31419977 [TBL] [Abstract][Full Text] [Related]
14. A Cost Variation Analysis of Drugs Available in the Indian Market for the Management of Thromboembolic Disorders. Ray A; Najmi A; Khandelwal G; Sadasivam B Cureus; 2020 May; 12(5):e7964. PubMed ID: 32523821 [TBL] [Abstract][Full Text] [Related]
15. Changes in prices, sales, consumer spending, and beverage consumption one year after a tax on sugar-sweetened beverages in Berkeley, California, US: A before-and-after study. Silver LD; Ng SW; Ryan-Ibarra S; Taillie LS; Induni M; Miles DR; Poti JM; Popkin BM PLoS Med; 2017 Apr; 14(4):e1002283. PubMed ID: 28419108 [TBL] [Abstract][Full Text] [Related]
16. Prices of combination medicines and single-molecule antihypertensive medicines in India's private health care sector. Negi S; Neupane D; Sahoo SK; Mahajan T; Swaroop K; Moran AE; Sharma B; Pathni AK J Clin Hypertens (Greenwich); 2021 Apr; 23(4):738-743. PubMed ID: 33369089 [TBL] [Abstract][Full Text] [Related]
17. Impact of pharmaceutical policy interventions on utilization of antipsychotic medicines in Finland and Portugal in times of economic recession: interrupted time series analyses. Leopold C; Zhang F; Mantel-Teeuwisse AK; Vogler S; Valkova S; Ross-Degnan D; Wagner AK Int J Equity Health; 2014 Jul; 13():53. PubMed ID: 25062657 [TBL] [Abstract][Full Text] [Related]
18. Retailer-Led Sugar-Sweetened Beverage Price Increase Reduces Purchases in a Hospital Convenience Store in Melbourne, Australia: A Mixed Methods Evaluation. Blake MR; Peeters A; Lancsar E; Boelsen-Robinson T; Corben K; Stevenson CE; Palermo C; Backholer K J Acad Nutr Diet; 2018 Jun; 118(6):1027-1036.e8. PubMed ID: 28870846 [TBL] [Abstract][Full Text] [Related]
19. Impact of three annual tobacco tax rises on tobacco sales in remote Australian Aboriginal community stores. Thomas DP; McMahon E; Wang Z; Scollo MM; Durkin SJ Tob Control; 2021 Dec; 30(e2):e122-e127. PubMed ID: 32967983 [TBL] [Abstract][Full Text] [Related]
20. Do cost containment policies save money and influence physicians' prescribing behavior? Lessons from South Korea's drug policy for diabetes medication. Kang SO; Kim SJ; Park S; Jang SI; Park EC Int J Qual Health Care; 2019 Mar; 31(2):96-102. PubMed ID: 29788203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]